Wei Chunzhu, Wang Jingbo, Yu Jintao, Tang Qing, Liu Xinjie, Zhang Yanlong, Cui Dandan, Zhu Yanqiong, Mei Yanli, Wang Yanjun, Wang Wenzhu
Department of Integrated Traditional and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Otolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chin Med. 2023 Mar 11;18(1):25. doi: 10.1186/s13020-023-00731-x.
Traumatic brain injury (TBI) is the leading cause of disability and death, and the social burden of mortality and morbidity caused by TBI is significant. Under the influence of comprehensive factors, such as social environment, lifestyle, and employment type, the incidence of TBI continues to increase annually. Current pharmacotherapy of TBI mainly focuses on symptomatic supportive treatment, aiming to reduce intracranial pressure, ease pain, alleviate irritability, and fight infection. In this study, we summarized numerous studies covering the use of neuroprotective agents in different animal models and clinical trials after TBI. However, we found that no drug has been approved as specifically effective for the treatment of TBI. Effective therapeutic strategies for TBI remain an urgent need, and attention is turning toward traditional Chinese medicine. We analyzed the reasons why existing high-profile drugs had failed to show clinical benefits and offered our views on the research of traditional herbal medicine for treating TBI.
创伤性脑损伤(TBI)是导致残疾和死亡的主要原因,TBI所致的死亡率和发病率带来的社会负担十分巨大。在社会环境、生活方式和就业类型等综合因素的影响下,TBI的发病率每年都在持续上升。目前TBI的药物治疗主要集中在对症支持治疗,旨在降低颅内压、缓解疼痛、减轻烦躁和抗感染。在本研究中,我们总结了众多关于TBI后在不同动物模型和临床试验中使用神经保护剂的研究。然而,我们发现尚无药物被批准对TBI治疗具有特效。TBI的有效治疗策略仍亟待解决,人们的注意力正转向传统中药。我们分析了现有备受瞩目的药物未能显示出临床益处的原因,并对治疗TBI的传统草药研究提出了我们的看法。